Literature DB >> 8407056

Enhancement of T-cell proliferation by PSK.

R Hirai1, Y Oguchi, N Sugita, K Matsunaga, K Nomoto.   

Abstract

Protein-bound polysaccharide, PSK, is a biological response modifier and influences various immunological functions in vivo, including those of T-cells. However, PSK has not been proved to stimulate proliferation of T-cells in vitro in contrast to various lines of evidence that indicate the proliferation of B-cells in vitro. PSK enhanced the proliferation of spleen cells in C3H/He and nude mice in vitro. In this study such proliferating cells were detected by monoclonal antibody to bromodeoxyuridine (BrdU) incorporated into DNA, and their subsets were determined by flowcytometry with monoclonal antibody to Thy1 as a cell surface marker of T-cells. When spleen cells from C3H/He mice were cultured with PSK for 3 days, the percentage of BrdU positive cells increased, and about 67% of BrdU positive cells were Thy1.2 positive. In addition, PSK also had the activity to enhance the proliferation in a T-cell-enriched fraction from spleen cells by nylon fiber columns as well as that in original spleen cells. These results suggest that PSK enhances the proliferation of T-cells as well as B-cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8407056     DOI: 10.1016/0192-0561(93)90147-q

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  6 in total

Review 1.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part III. Proliferation in normal, injured and diseased tissue, growth factors, differentiation, DNA replication sites and in situ hybridization.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1996-08

Review 2.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1995-12

3.  Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells.

Authors:  Hailing Lu; Yi Yang; Ekram Gad; Cynthia A Wenner; Amy Chang; Emily R Larson; Yushe Dang; Mark Martzen; Leanna J Standish; Mary L Disis
Journal:  Clin Cancer Res       Date:  2010-11-10       Impact factor: 12.531

4.  Immune defects in breast cancer patients after radiotherapy.

Authors:  Leanna J Standish; Carolyn Torkelson; Frank A Hamill; Daesong Yim; Alicia Hill-Force; Annette Fitzpatrick; Monica Olsen; Sandi Schildt; Erin Sweet; Cynthia A Wenner; Mark R Martzen
Journal:  J Soc Integr Oncol       Date:  2008

5.  Biological response modifiers (BRM) as antigens. III. T cell lines specific for BRM kill tumor cells in a BRM-specific manner.

Authors:  S Ozaki; T Okazaki; K Nakao
Journal:  Cancer Immunol Immunother       Date:  1995-04       Impact factor: 6.968

6.  Can polysaccharide K improve therapeutic efficacy and safety in gastrointestinal cancer? a systematic review and network meta-analysis.

Authors:  Yan Ma; Xiaofen Wu; Jingwen Yu; Jinyan Zhu; Xia Pen; Xianjun Meng
Journal:  Oncotarget       Date:  2017-07-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.